Contact Us

Biovica invites to telephone conference/audiocast

2019-09-18 08:00

Uppsala, Sweden, September 18, 2019. Biovica invites investors, analysts and the media to a presentation where Anders Rylander, CEO, and Mattias Bergqvist, Clinical Development Director, comments on today’s announcement. The presentation will be held on 19 September 2019 at 10:00 CET and can be followed via telephone conference or audiocast.

The presentation will be held in English and will be followed by a questions and answers session. Questions can be asked via the telephone conference or in written form via the audiocast. No pre-registration is needed.

Participant dial in number

DK: +4578150109

SE: +46856642703

UK: +443333009030

US: +18338230589

The presentation can also be viewed live at:

https://tv.streamfabriken.com/2019-09-19-biovica-international-press-conference

Afterwards, a recording of the presentation will be available at the same page.

For more information
Anders Rylander, CEO Biovica
phone: +46 (0)18 444 48 35
email: anders.rylander@biovica.com

Some of our Collaborations

>3200

Numbers of patients in studies

24

Publications

10

Pharma Contracts

Are you based in the US?

No